Duality Biotherapeutics, Inc. (4ZB)
Market Open
18 Aug, 07:31
XDUS XDUS Primary 
HKEX €
19. 70
-0.2
-1.005%
€
- Market Cap
- P/E Ratio
- Div Yield
0 Volume
- Eps
€ 19.9
Previous Close Want to track 4ZB and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Duality Biotherapeutics, Inc. (4ZB) Statistics
Valuation metrics
Market Cap -
Enterprise value 5.32M
Trailing P/E (ttm) -
Forward P/E -
PEG ratio -
Price/Sales (ttm) -
Price/Book (mrq) 7.11
Enterprise Value/Revenue 0.02
Enterprise Value/EBITDA -0.09
Overview
Shares outstanding -
Float 50.45M
Shares short -
% Held by insiders 0.46%
% Held by institutions 0.42%
Average volume (10 days) 2
Average volume (90 days) 1
Price summary
52-Week low 17.6
52-Week high 57.5
Beta -
50-Day moving average 43.92
200-Day moving average 43.92
Financials
Fiscal year
Fiscal year ends 31 Dec 2025
Most recent quarter (mrq) 31 Dec 2025
Profitability
Profit margin -1.4%
Operating margin -0.93%
Operational effectiveness
Return on assets -0.1%
Return on equity -12.82%
Income Statement
Revenue (ttm) 233.93M
Revenue per share (ttm) 28.42
Quarterly revenue growth (yoy) -0.34%
Gross profit (ttm) 74.42M
EBITDA -57.19M
Net income to common (ttm) -327.8M
Diluted EPS (ttm) -
Quarterly earnings growth (yoy) -
Balance Sheet
Total cash (mrq) 427.02M
Total cash per share (mrq) 37.8
Total debt (mrq) 18.92M
Total Debt/Equity (mrq) 6.17
Current ratio (mrq) 3.65%
Book value per share (mrq) 3.43
Cash Flow
Cash flow statement 24.58M
Levered free cash flow (LFCF) -383.71M
